Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Letsch

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
Journal of Translational Medicine|January 17, 2009
High correlation of the proteome patterns in bone marrow and peripheral blood blast cells in patients with acute myeloid leukemiaGero Hütter, Anne Letsch, Daniel Nowak, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 22, 2022
Clinical endpoints in trials of palliative radiotherapy: A systematic meta-research analysisAlexander Fabian, Justus Domschikowski, Anne Letsch, et al.
JAMA Network Open|September 22, 2022
Use and Reporting of Patient-Reported Outcomes in Trials of Palliative Radiotherapy: A Systematic ReviewAlexander Fabian, Justus Domschikowski, Anne Letsch, et al.
BMC Cancer|October 27, 2015
Cancer-testis antigen cyclin A1 is broadly expressed in ovarian cancer and is associated with prolonged time to tumor progression after platinum-based therapyRuza Arsenic, Elena Ilona Braicu, Anne Letsch, et al.
The Journal of Investigative Dermatology|April 17, 2004
Functional CCR9 expression is associated with small intestinal metastasisAnne Letsch, Ulrich Keilholz, Dirk Schadendorf, et al.
International Journal of Cancer|April 4, 2003
Differences in T-cell immunity toward tumor-associated antigens in colorectal cancer and breast cancer patientsDirk Nagorsen, Carmen Scheibenbogen, Gerhard Schaller, et al.
Blood|August 30, 2002
CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemiaCarmen Scheibenbogen, Anne Letsch, Eckhard Thiel, et al.
International Journal of Cancer|October 10, 2009
Long term presence of a single predominant tyrosinase-specific T-cell clone associated with disease control in a patient with metastatic melanomaSebastian Ochsenreither, Alberto Fusi, Antonia Busse, et al.
European Journal of Cancer Care|January 10, 2019
Early palliative care for those who care: A qualitative exploration of cancer caregivers' information needs during hospital staysMartina Preisler, Amy Rohrmoser, Ute Goerling, et al.
Cancer Immunology, Immunotherapy : CII|September 8, 2011
Wilms' tumor protein 1 (WT1) peptide vaccination in AML patients: predominant TCR CDR3β sequence associated with remission in one patient is detectable in other vaccinated patientsSebastian Ochsenreither, Alberto Fusi, Anne Geikowski, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Journal of Translational Medicine|January 17, 2009
High correlation of the proteome patterns in bone marrow and peripheral blood blast cells in patients with acute myeloid leukemiaGero Hütter, Anne Letsch, Daniel Nowak, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 22, 2022
Clinical endpoints in trials of palliative radiotherapy: A systematic meta-research analysisAlexander Fabian, Justus Domschikowski, Anne Letsch, et al.
JAMA Network Open|September 22, 2022
Use and Reporting of Patient-Reported Outcomes in Trials of Palliative Radiotherapy: A Systematic ReviewAlexander Fabian, Justus Domschikowski, Anne Letsch, et al.
BMC Cancer|October 27, 2015
Cancer-testis antigen cyclin A1 is broadly expressed in ovarian cancer and is associated with prolonged time to tumor progression after platinum-based therapyRuza Arsenic, Elena Ilona Braicu, Anne Letsch, et al.
The Journal of Investigative Dermatology|April 17, 2004
Functional CCR9 expression is associated with small intestinal metastasisAnne Letsch, Ulrich Keilholz, Dirk Schadendorf, et al.
International Journal of Cancer|April 4, 2003
Differences in T-cell immunity toward tumor-associated antigens in colorectal cancer and breast cancer patientsDirk Nagorsen, Carmen Scheibenbogen, Gerhard Schaller, et al.
Blood|August 30, 2002
CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemiaCarmen Scheibenbogen, Anne Letsch, Eckhard Thiel, et al.
International Journal of Cancer|October 10, 2009
Long term presence of a single predominant tyrosinase-specific T-cell clone associated with disease control in a patient with metastatic melanomaSebastian Ochsenreither, Alberto Fusi, Antonia Busse, et al.
European Journal of Cancer Care|January 10, 2019
Early palliative care for those who care: A qualitative exploration of cancer caregivers' information needs during hospital staysMartina Preisler, Amy Rohrmoser, Ute Goerling, et al.
Cancer Immunology, Immunotherapy : CII|September 8, 2011
Wilms' tumor protein 1 (WT1) peptide vaccination in AML patients: predominant TCR CDR3β sequence associated with remission in one patient is detectable in other vaccinated patientsSebastian Ochsenreither, Alberto Fusi, Anne Geikowski, et al.
Pageof 9